New York, NY -- (SBWIRE) -- 01/10/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: New Residential Investment Corp (NYSE:NRZ), CYS Investments Inc (NYSE:CYS), Standard Pacific Corp (NYSE:SPF), Immunomedics, Inc (NASDAQ:IMMU)
New Residential Investment Corp (NYSE:NRZ) showed a volume of 2.13 million shares by the end of last trade whereas the average volume of the stock remained 2.06 million shares. The stock opened the session at $6.55 but then moved to $6.43. At that price, the stock showed a negative performance of -1.38%. New Residential Investment Corp., incorporated on September 26, 2013, is a real estate investment trust. The Company focuses on investing in, and actively managing, investments related to residential real estate. The Company is managed by an affiliate of Fortress Investment Group LLC, a global investment management.
Will NRZ Get Buyers Even After The Recent Rally? Find Out Here
CYS Investments Inc (NYSE:CYS) opened the session at $7.65 and closed the session at $7.54. The stock showed a negative performance of -1.05% in previous trading session. CYS Investments, Inc. is a specialty finance company created with the objective of achieving consistent risk-adjusted investment income. The Company invests in Agency residential mortgage-backed securities (RMBS) collateralized by fixed rate single-family residential mortgage loans (typically 15, 20 or 30 years), adjustable-rate mortgage loans (ARMs), which typically have coupon rates that reset monthly, or hybrid ARMs, which typically have a coupon rate that is fixed for an initial period (typically three, five, seven or 10 years) and thereafter resets at regular intervals.
Has CYS Found The Bottom And Ready To Gain Momentum? Find Out Here
Standard Pacific Corp (NYSE:SPF) opened the session at $8.85 and closed the session at $8.77. The stock showed a negative performance of -0.79% in previous trading session. The beta of the stock remained 3.05. Standard Pacific Corp. is a geographically diversified business spans many of the housing markets, including metropolitan markets in California, Florida, the Carolinas, Texas, Arizona, and Colorado. The Company operates in two principal businesses: homebuilding and financial services (consisting of its mortgage financing and title operations).
Why Should Investors Buy SPF After the Recent Fall? Just Go Here and Find Out
Immunomedics, Inc (NASDAQ:IMMU) the stock advanced 5.71% and finished the session at $5.18. Traded with volume of 2.36 million shares in the prior session and the average volume of the stock remained 940,615.00 shares. The beta of the stock remained 1.91. Immunomedics, Inc. is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. The Company has developed a number of advanced technologies that allow the Company to create humanized antibodies that can be used either alone in unlabeled or naked form,
Will IMMU Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)